Guías clínicas de diagnóstico y tratamiento de la encefalopatía hepática. Tratamiento y perspectivas a futuro

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Revista Portuguesa De Pneumologia

• Publication date

  2009-04-01

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• l‐Ornithine‐l‐aspartate in the management of hepatic encephalopathy: A meta‐analysis

  2009cited by this paper
• Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure

  2009cited by this paper
• Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis

  2007cited by this paper
• Hospitalizations During the Use of Rifaximin Versus Lactulose for the Treatment of Hepatic Encephalopathy

  2007cited by this paper
• Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.

  2006cited by this paper
• Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet.

  2005cited by this paper
• Effect of glutamine synthetase inhibition on astrocyte swelling and altered astroglial protein expression during hyperammonemia in rats.

  2005cited by this paper
• Rifaximin, a nonabsorbed oral antibiotic, in the treatment of hepatic encephalopathy: antimicrobial activity, efficacy, and safety.

  2005cited by this paper
• Role of antibiotics in the management of hepatic encephalopathy.

  2005cited by this paper
• Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats.

  2005cited by this paper
• Normal protein diet for episodic hepatic encephalopathy: results of a randomized study.

  2004cited by this paper
• Benzodiazepine receptor antagonists for hepatic encephalopathy.

  2004cited by this paper
• Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy

  2004cited by this paper
• Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta‐analysis

  2002cited by this paper
• Normalization of T2 signal abnormalities in hemispheric white matter with liver transplant

  2002cited by this paper
• Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS

  2002cited by this paper
• Prognostic significance of hepatic encephalopathy in patients with cirrhosis.

  1999cited by this paper
• Therapeutic efficacy of L‐ornithine‐L‐aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo‐controlled, double‐blind study

  1997cited by this paper
• Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized cross‐over comparison

  1993cited by this paper
• Double-blind, double-dummy comparison between treatment with rifaximin and lactulose in patients with medium to severe degree hepatic encephalopathy.

  1993cited by this paper
• Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy.

  1990cited by this paper
• Clinical pharmacology of flumazenil.

  1988cited by this paper
• Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal‐systemic encephalopathy: A double‐blind, randomized clinical trial

  1987cited by this paper
• Treatment of hepatic encephalopathy with metronidazole.

  1982cited by this paper
• Effects of lactulose and neomycin on urea metabolism in cirrhotic subjects.

  1982cited by this paper
• Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy

  1981cited by this paper
• Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy

  1978cited by this paper
• Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.

  1977cited by this paper
• Liver transplantation.

  1967cited by this paper

• Current vision on diagnosis and comprehensive care in hepatic encephalopathy.

  2023cites this paper
• The most highly cited articles of the Revista de Gastroenterología de México over a 22-year period (1996-2018)

  2021cites this paper
• The most highly cited articles of the Revista de Gastroenterología de México over a 22-year period (1996-2018).

  2021cites this paper
• Efficacy of rifaximin in the different clinical scenarios of hepatic encephalopathy

  2020cites this paper
• Sarcopenia secundaria en la encefalopatía hepática: Implicaciones para el seguimiento nutricional

  2020cites this paper
• Efficacy of rifaximin in the different clinical scenarios of hepatic encephalopathy.

  2019cites this paper